Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction

Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction

<p>Abstract</p> <p>Cardiac magnetic resonance (CMR) offers a variety of parameters potentially suited as surrogate endpoints in clinical trials of acute myocardial infarction such as infarct size, myocardial salvage, microvascular obstruction or left ventricular volumes and ejectio...

Full description

Bibliographic Details
Main Authors:	Gutberlet Matthias, Lurz Philipp, Fuernau Georg, de Waha Suzanne, Eitel Ingo, Desch Steffen, Schuler Gerhard, Thiele Holger
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Trials
Subjects:	Myocardial infarction surrogate endpoints cardiac magnetic resonance imaging validity reliability clinical trial
Online Access:	http://www.trialsjournal.com/content/12/1/204

Similar Items

Surrogate endpoints in trials: a call for better reporting
by: Oriana Ciani, et al.
Published: (2022-12-01)

Surrogate endpoint evaluation using data from one large global randomized controlled trial
by: Milan Geybels, et al.
Published: (2021-05-01)

Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011
by: Behnood Bikdeli, et al.
Published: (2017-03-01)

Relationship and prognostic value of microvascular obstruction and infarct size in st-elevation myocardial infarction as visualized by magnetic resonance imaging
by: Gutberlet Matthias, et al.
Published: (2011-02-01)

Impact of gender on the prevalence and extent of microvascular obstruction after st-elevation myocardial infarction
by: Thiele Holger, et al.
Published: (2011-02-01)

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsResearch in context
by: Oriana Ciani, et al.
Published: (2023-11-01)

Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction
by: Schuler Gerhard, et al.
Published: (2011-02-01)

Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer
by: Hideki Maeda, et al.
Published: (2021-06-01)

Combining Correlated Outcomes and Surrogate Endpoints in a Network Meta-Analysis of Colorectal Cancer Treatments
by: Tung Hoang, et al.
Published: (2020-09-01)

Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)
by: Lassere Marissa N, et al.
Published: (2012-03-01)

Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trialsResearch in context
by: Zhishan Zhang, et al.
Published: (2023-09-01)

A randomised controlled trial is not a pilot trial simply because it uses a surrogate endpoint
by: M. J. Campbell, et al.
Published: (2018-07-01)

Impact of chronic statin-pretreatment on myocardial damage as assessed by Cardiac Magnetic Resonance findings in patients with acute ST-elevation myocardial infarction
by: Fuernau Georg, et al.
Published: (2012-02-01)

Gender differences in myocardial salvage and clinical outcome in patients with acute reperfused ST-elevation myocardial infarction
by: Schuler Gerhard, et al.
Published: (2011-02-01)

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints
by: Wenbo Zhu, et al.
Published: (2017-09-01)

Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?
by: Robert Kemp, et al.
Published: (2017-07-01)

Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction
by: Gianluigi Savarese, et al.
Published: (2022-08-01)

Prognostic significance of papillary muscle infarction detected by late gadolinium-enhanced MRI in acute reperfused ST-segment elevation myocardial infarction
by: Eitel Ingo, et al.
Published: (2013-01-01)

Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction
by: Schuler Gerhard, et al.
Published: (2010-01-01)

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
by: Giuseppe Cabibbo, et al.
Published: (2020-12-01)

Incorporating Covariates into Measures of Surrogate Paradox Risk
by: Fatema Shafie Khorassani, et al.
Published: (2023-02-01)

Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
by: Willem Collier, et al.
Published: (2024-02-01)

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
by: Jianyang Liu, et al.
Published: (2022-04-01)

The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status
by: Heather Poad, et al.
Published: (2022-11-01)

Evaluation of Surrogate Endpoints Using Information-Theoretic Measure of Association Based on Havrda and Charvat Entropy
by: María del Carmen Pardo, et al.
Published: (2022-01-01)

A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial
by: Li Zhang, et al.
Published: (2022-11-01)

Selection of Endpoints for Clinical Studies of Ophthalmic Drugs
by: M. O. Komarova
Published: (2021-10-01)

Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Myocardial and Microvascular Injury in Acute Myocardial Infarction: Insights From the Randomized MonAMI Trial
by: Thomas Stiermaier, et al.
Published: (2021-05-01)

Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China
by: Kexin Ling, et al.
Published: (2022-11-01)

Progression-Free Survival as Early Efficacy Endpoint in Resectable Esophageal Cancer Treated With Neoadjuvant Therapy: A Systematic Review
by: Jie Zhu, et al.
Published: (2022-01-01)

Additional impact of microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after st-elevation myocardial infarction - a comparison to traditional prognostic markers
by: Schuler Gerhard, et al.
Published: (2010-01-01)

A proposal to analyze the progression of non-dialytic chronic kidney disease by surrogate endpoints: introducing parametric survival models
by: Renato Erohildes Ferreira, et al.
Published: (2023-05-01)

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer
by: Shuang Zhang, et al.
Published: (2021-07-01)

Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings
by: Tiantian Hua, et al.
Published: (2022-09-01)

Progression‐free survival assessed per immune‐related or conventional response criteria, which is the better surrogate endpoint for overall survival in trials of immune‐checkpoint inhibitors in lung cancer: A systematic review and meta‐analysis
by: Guang‐Li Zhu, et al.
Published: (2021-12-01)

Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review
by: Ionut-Gabriel Funingana, et al.
Published: (2022-10-01)

Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation
by: Mark J. Bolland, et al.
Published: (2018-10-01)

Effect of estimating equations for glomerular filtration rate on novel surrogate markers for renal outcome
by: Kipyo Kim, et al.
Published: (2021-06-01)

Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited
by: Markus Diefenhardt, et al.
Published: (2022-07-01)

Patient Centered Outcomes in Periodontal Treatment-An Evidenced Based Approach
by: Ekta Bharatbhai Shah, et al.
Published: (2017-04-01)